Artículos por temáticas

[Prevention Methods for Social Isolation, Loneliness, and Dementia]

Shimoda Y, Urakami K.

Brain Nerve. 2025 Feb;77(2):127-132. doi: 10.11477/mf.188160960770020127.

Insights for dementia risk reduction among lower SES adults in OECD countries: scoping review of interventions targeting multiple common health risk factors

Coates AL, Fair HL, Lea EJ, Doherty KV.

Int J Equity Health. 2025 Feb 24;24(1):52. doi: 10.1186/s12939-025-02386-6.

Evaluating the Clinical Efficacy of an Exergame-Based Training Program for Enhancing Physical and Cognitive Functions in Older Adults With Mild Cognitive Impairment and Dementia Residing in Rural Long-Term Care Facilities: Randomized Controlled Trial

Li A, Qiang W, Li J, Geng Y, Qiang Y, Zhao J.

J Med Internet Res. 2025 Feb 19;27:e69109. doi: 10.2196/69109.

An autopsy case of type A FTLD-TDP with a GRN mutation presenting with the logopenic variant of primary progressive aphasia at onset and with corticobasal syndrome subsequently

Tomenaga T, Minatani S, Namba H, Takeda A, Yoshizaki T, Kawabe J, Keyoumu N, Morino H, Higuchi M, Matsubara T, Hatsuta H, Hasegawa M, Murayama S, Itoh Y.

Neuropathology. 2025 Feb;45(1):38-47. doi: 10.1111/neup.12980. Epub 2024 May 7.

A New Computer-Based Cognitive Measure for Early Detection of Dementia Risk (Japan Cognitive Function Test): Validation Study

Shimada H, Doi T, Tsutsumimoto K, Makino K, Harada K, Tomida K, Morikawa M, Makizako H.

J Med Internet Res. 2025 Feb 14;27:e59015. doi: 10.2196/59015.

The need for personalization when sharing results of amyloid imaging for Alzheimer's disease: Insights from a randomized experimental study

Fruijtier AD, van der Flier WM, van Maurik I, van der Schaar J, Pijnenburg YAL, Smets EMA, Visser LNC.

Patient Educ Couns. 2025 Feb;131:108587. doi: 10.1016/j.pec.2024.108587. Epub 2024 Nov 28.

Favorable long-term cognitive outcomes following recurrent ARIA linked to amyloid-lowering therapies: two cases

Zavarella M, Cecchetti G, Rugarli G, Ghirelli A, Bottale I, Orlandi F, Spinelli EG, Santangelo R, Caso F, Calloni SF, Vezzulli PQ, Falini A, Magnani G, Agosta F, Filippi M.

J Neurol. 2025 Jan 24;272(2):168. doi: 10.1007/s00415-025-12910-x.

Protocol for an intergenerational randomized controlled trial to enhance physical activity in older adults at risk for Alzheimer's disease

Walker CS, Noriega de la Colina AE, Li L, Boulanger C, Thovinakere N, Noly-Gandon A, Barnoin G, Bennett M, Caplan J, Côté L, Elbaz S, Bao SFK, Kara R, Lavoie N, Nguyen M, Otaner F, Pallett-Wiesel H, P

J Prev Alzheimers Dis. 2025 Mar;12(3):100039. doi: 10.1016/j.tjpad.2024.100039. Epub 2025 Jan 9.

Grey-Matter Structure Markers of Alzheimer's Disease, Alzheimer's Conversion, Functioning and Cognition: A Meta-Analysis Across 11 Cohorts

Couvy-Duchesne B, Frouin V, Bouteloup V, Koussis N, Sidorenko J, Jiang J, Wink AM, Lorenzini L, Barkhof F, Trollor JN, Mangin JF, Sachdev PS, Brodaty H, Lupton MK, Breakspear M, Colliot O, Visscher PM

Hum Brain Mapp. 2025 Feb 1;46(2):e70089. doi: 10.1002/hbm.70089.

Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down Syndrome: A Case Report

Rodríguez-Baz Í, Benejam B, Morcillo-Nieto AO, Vaqué-Alcázar L, Arriola-Infante JE, Camacho V, Aranha MR, Carmona-Iragui M, Videla L, Barroeta I, Fernández S, Zsadanyi SE, Giménez S, Arranz J, Maure B

Neurology. 2025 Jan 14;104(1):e210179. doi: 10.1212/WNL.0000000000210179. Epub 2024 Dec 17.

Comparison of the amyloid plaque proteome in Down syndrome, early-onset Alzheimer's disease, and late-onset Alzheimer's disease

Martá-Ariza M, Leitner DF, Kanshin E, Suazo J, Giusti Pedrosa A, Thierry M, Lee EB, Devinsky O, Drummond E, Fortea J, Lleó A, Ueberheide B, Wisniewski T.

Acta Neuropathol. 2025 Jan 18;149(1):9. doi: 10.1007/s00401-025-02844-z.

Pre-treatment subjective sleep quality as a predictive biomarker of tDCS effects in preclinical Alzheimer's disease patients: Secondary analysis of a randomised clinical trial

Lu H, Ni X, Man Chan SS, Cheng CPW, Chan W, Lam LCW.

PLoS One. 2025 Jan 28;20(1):e0317700. doi: 10.1371/journal.pone.0317700. eCollection 2025.

Advancing Alzheimer's disease risk prediction: development and validation of a machine learning-based preclinical screening model in a cross-sectional study

Wang B, Xie R, Qi W, Yao J, Shi Y, Lou X, Dong C, Zhu X, Wang B, He D, Chen Y, Cao S.

BMJ Open. 2025 Feb 8;15(2):e092293. doi: 10.1136/bmjopen-2024-092293.

Association of Seizure Control with Mortality, Cognition, and Function in People With Dementia

Zawar I, Quigg M, Ghosal S, Punia V, Calle-Lopez Y, Manning C, Kapur J.

Ann Neurol. 2025 Feb;97(2):358-368. doi: 10.1002/ana.27125. Epub 2024 Oct 30.

The Alzheimer's Association clinical practice guideline for the diagnostic evaluation, testing, counseling, and disclosure of suspected Alzheimer's disease and related disorders (DETeCD-ADRD): Validated clinical assessment instruments

Atri A, Dickerson BC, Clevenger C, Karlawish J, Knopman D, Lin PJ, Norman M, Onyike C, Sano M, Scanland S, Carrillo M.

Alzheimers Dement. 2025 Jan;21(1):e14335. doi: 10.1002/alz.14335. Epub 2024 Dec 23.